Evolving Approaches To Rx Patient Assistance
Loreen Brown, SVP, Product Strategy & Commercialization, contributes to this article in Specialty Pharmacy Continuum
The pharmaceutical industry now spends around $15 billion annually on patient assistance programs (PAPs) designed to help patients afford their increasingly high medication copays, according to CareNet Foundation, a North Carolina–based PAP service organization.
The national Partnership for Prescription Assistance estimates that it works with more than 475 public and private programs, including more than 200 offered by pharmaceutical companies.
Leading pharmacy services firms such as Cardinal Health and global health care solutions leader AmerisourceBergen are taking their own approaches to optimizing the benefits of PAP programs, while at the same time working to transition patients who are using these programs to more comprehensive health insurance coverage under the Affordable Care Act.